Dubbed a patient-in-residence at Bakar Bio Labs, where he was embedded earlier this year with gene therapy startup NV ...
The San Antonio Business Journal will host the Impact Awards on Nov. 4, 2026, celebrating the Impact of people and businesses ...
The Embolden trial builds on positive interim data from the Phase 1/2 trial of NGN-401, which demonstrated multidomain, durable gains with continued developmental milestone acquisitions as of the most ...
Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results